{
    "clinical_study": {
        "@rank": "139495", 
        "arm_group": [
            {
                "arm_group_label": "Major Depressive Disorder"
            }, 
            {
                "arm_group_label": "Healthy Control"
            }
        ], 
        "biospec_descr": {
            "textblock": "We will be retaining biospecimens including, whole blood, serum, hair and saliva tissues\n      samples."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The primary objective of this study is to investigate the biological components of major\n      depression. The investigators are particularity interested in genetic variation and how it\n      contributes to cortisol (because cortisol is higher in severe depression than mild\n      depression or healthy controls) and how it contributes to clinical symptoms, especially\n      suicidal ideation/behavior and psychosis."
        }, 
        "brief_title": "Identifying Biological Markers for Severe Depression", 
        "completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Major Depressive Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria for depressed patients:\n\n          1. Diagnostic and Statistical Manuel of Mental Disorders 4th Edition (DSM-IV) diagnosis\n             of Unipolar Major Depressive Disorder with or without psychotic features.\n\n          2. 21-item Hamilton Depression Rating Scale (HDRS) score greater than or equal to 21.\n\n          3. Thase Core Endogenomorphic Scale score greater than or equal to 8 on the items\n             included in the 21-item HDRS.\n\n          4. Between 21 - 70 years of age.\n\n          5. If currently taking antipsychotic, antidepressant, anticonvulsant, and/or\n             mood-stabilizing medications, must be stable on the medication for at least one-week\n             prior to entering the study.\n\n          6. Pre-existing (current) primary treating psychiatrist for subjects with psychotic\n             features.\n\n          7. Any secondary diagnoses from the anxiety disorder spectrum is acceptable. Primary\n             pre-existing chronic Obsessive-Compulsive Disorder (OCD) will be an exclusion\n             criteria.\n\n        Inclusion criteria for healthy controls:\n\n          1. Between 21 - 70 years of age.\n\n          2. Have a HAM-D score of less than or equal to 5.\n\n        Exclusion Criteria for depressed patients:\n\n          1. Electroconvulsive Therapy (ECT) in the 6 months prior to the study.\n\n          2. Abuse of drugs or alcohol in the 6 months prior to study.\n\n          3. Unstable or untreated hypertension or cardiovascular disease.\n\n          4. Use of additional prescription medications, street drugs, or alcohol during the week\n             before the study.\n\n          5. Any Axis II diagnosis or traits which would make participation in the study\n             difficult.\n\n          6. Current pregnancy or lactation.\n\n          7. Post-partum depression\n\n          8. Diagnosis of obsessive-compulsive disorder\n\n          9. History of significant cognitive decline\n\n        Exclusion criteria for healthy controls:\n\n          1. Personal history of Axis I or Axis II disorders.\n\n          2. Active unstable medical problems.\n\n          3. Abuse of drugs or alcohol in the 6 months prior to study.\n\n          4. Use of additional prescription medications, street drugs, or alcohol during the week\n             before the study.\n\n          5. Currently pregnant or lactating.\n\n          6. History of significant cognitive decline"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Inpatient hospitals, outpatient clinics, community."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01831882", 
            "org_study_id": "26529"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 24, 2014", 
        "link": {
            "description": "Stanford Depression Research Clinic Website", 
            "url": "http://med.stanford.edu/depression/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "jvpatter@uci.edu", 
                    "last_name": "Julie Patterson, Ph.D.", 
                    "phone": "714-456-1663"
                }, 
                "facility": {
                    "address": {
                        "city": "Irvine", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92697"
                    }, 
                    "name": "University of California, Irvine"
                }, 
                "investigator": [
                    {
                        "last_name": "William E. Bunney, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Julie Patterson, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Richard Stein, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Mark Vawter, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Preston Cartagena, PsyD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Blynn Bunney, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Steven G. Potkin, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "P. Adolfo Sequeira Medieta, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "shill@stanford.edu", 
                    "last_name": "Shelley J Hill, M.S.", 
                    "phone": "650-723-3305"
                }, 
                "facility": {
                    "address": {
                        "city": "Stanford", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94305"
                    }, 
                    "name": "Stanford University, Department of Psychiatry and Behavioral Sciences"
                }, 
                "investigator": [
                    {
                        "last_name": "Alan Schatzberg, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Jennifer Keller, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rowena Gomez, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Justin A. Birnbaum, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rona Hu, M.D.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pam2029@med.cornell.edu", 
                    "last_name": "Patricia Marino, PhD", 
                    "phone": "914-997-8691"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Weill Cornell Medical College"
                }, 
                "investigator": [
                    {
                        "last_name": "Benjamin Brody, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "James Kocsis, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jack Barchas, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Barnett Meyers, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Patricia Marino, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Meredith Grossman, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Identifying Biological Markers for Severe Depression", 
        "other_outcome": [
            {
                "description": "Cortisol hormone levels will be measured in blood (suppression test), hair and saliva samples.", 
                "measure": "Physiologic", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Standardized neuropsychological measures will be used to assess neurocognition including, tests involving verbal learning, visual reproduction, attentional flexibility, and memory.", 
                "measure": "Neurocognition", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Clinical psychiatric measures will be used to assess depression (HAM-D), psychotic features, suicidality, childhood trauma, and anhedonia.", 
                "measure": "Clinical", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "overall_contact": {
            "email": "shill@stanford.edu", 
            "last_name": "Shelley J Hill, M.S."
        }, 
        "overall_official": {
            "affiliation": "Stanford University", 
            "last_name": "Alan Schatzberg, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Blood will be drawn for gene expression, which includes genetics and metallothionein assessments. Blood will also be drawn for later assay of immune function/measures and neurotophins, and for future studies.", 
            "measure": "Genetics", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01831882"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Stanford University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Cornell University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of California, Irvine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Pritzker Consortium", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Stanford University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}